Lucknow: Chronic Myeloid Leukemia (CML) — which forms a major share of adult blood cancer cases in Uttar Pradesh — can now be ...
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is one of the Hottest Small Cap Stocks to Buy Now. On November 11, Andy Hsieh from ...
Patients with CML, unlike patients with acute lymphoblastic leukemia, are likely to have a longer life expectancy with and ...
The FDA approves generic dasatinib tablets, enhancing access and affordability for treating chronic myeloid leukemia and ...
We recently published 10 Firms Shining Bright in a Bleeding Market. Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is one of the ...
Updated clinical development strategy based on positive data In the third quarter of 2025, Mendus shaped up its clinical development plans for the lead program vididencel in myeloid malignancies.The u ...
GSK Canada is pleased to announce that Ojjaara (momelotinib) will now be reimbursed by Régie de l’assurance maladie du Québec ...
Vadodara: Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug ...
A lower number of CD26+ LSCs at diagnosis correlates with optimal molecular response in CML patients at 3, 12, and 24 months.
Alembic Pharma received USFDA approval for its generic Dasatinib Tablets (20–140 mg), equivalent to Sprycel by BMS. The drug ...
Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Dasatinib Tablets, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback